Dynamic modulated brachytherapy (DMBT) for rectal cancer.

PURPOSE All forms of past and current high-dose-rate brachytherapy utilize immobile applicators during treatment delivery. The only moving part is the source itself. This paradigm misses an important degree of freedom that, if explored, can in some instances produce previously unachievable dose conformality; that is, the dynamic motion of the applicator itself during treatment delivery. Monte Carlo and treatment planning simulations were used to illustrate the potential benefits of moving applicators for rectal cancer applications in particular. This concept is termed dynamic modulated brachytherapy (DMBT). METHODS The DMBT system uses a high-density, 18.0 g∕cm(3), 45 mm long tungsten alloy shield, cylindrical in shape, with a small window on one side to encapsulate a (192)Ir source, to create collimation that results in a highly directional beam profile. This shield can be dynamically translated and rotated, using an attached robotic arm, during treatment to create a volumetric modulated arc therapy-type delivery, but from inside the rectal cavity. Monte Carlo simulations and planning optimization algorithms were developed inhouse to evaluate the effectiveness of this new approach using 36 clinical treatment plans comprised of 13 patients each treated using the intracavitary mold applicator (ICMA, Nucletron, The Netherlands) to quantify the potential clinical benefit. The prescription dose was 10 Gy∕fx and the group had an average clinical target volume of 9.0 ± 3.5 cm(3). Ideal phantom geometries were used to evaluate the impact of various shield dimensions and designs on the resulting plan quality. RESULTS Simulations of ideal phantom geometries found that shields as small as 10 mm in diameter can produce high quality plans. For the clinical patient cases, compared to the ICMA, for equal prescription tumor coverage, the DMBT plans provided >30% decrease in D(5) (high dose volume) resulting in a ∼40% decrease in dose heterogeneity index. In addition, mean dose and D(98) showed a reduction (typically 40%-60%) on all critical structures evaluated. However, for a 10 Gy prescribed dose there was an increase in total treatment time on average from 7.6 to 20.8 min for a source with an air-kerma strength of 40.25 kU (10 Ci). CONCLUSIONS Dosimetric properties of a novel DMBT system have been described and evaluated. Comparison with the ICMA commercial applicator has shown it to be a prospective step forward in high-dose-rate brachytherapy (192)Ir technology. Dynamic motion of an applicator during treatment, for any applicator and site in general, can provide additional degrees of freedom that, if properly considered, can potentially increase the plan quality significantly.

[1]  D. Ryan,et al.  T3N0 rectal cancer: radiation for all? , 2011, Seminars in radiation oncology.

[2]  Slobodan Devic,et al.  Risk of hypogonadism from scatter radiation during pelvic radiation in male patients with rectal cancer. , 2009, International journal of radiation oncology, biology, physics.

[3]  D P Fontenla,et al.  Comparison of the transit dose components and source kinematics of three high dose rate afterloading systems. , 1999, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

[4]  V S Ramani,et al.  Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes? , 2010, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

[5]  S. Civjan,et al.  Potential Applications of Certain Nickel-Titanium (Nitinol) Alloys , 1975, Journal of dental research.

[6]  Inger-Karine K Kolkman-Deurloo,et al.  Intraoperative HDR brachytherapy for rectal cancer using a flexible intraoperative template: standard plans versus individual planning. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Peter Bownes,et al.  High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  J. D. de Visscher,et al.  Results of radiotherapy for squamous cell carcinoma of the vermilion border of the lower lip. A retrospective analysis of 108 patients. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Slobodan Devic,et al.  High-dose-rate endorectal brachytherapy in the treatment of locally advanced rectal carcinoma: technical aspects. , 2005, Brachytherapy.

[10]  J. Williamson,et al.  Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source. , 1998, Medical physics.

[11]  Jatinder R Palta,et al.  Conceptual Source Design and Dosimetric Feasibility Study for Intravascular Treatment: A Proposal for Intensity Modulated Brachytherapy , 2003 .

[12]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[13]  S. Webb Optimisation of conformal radiotherapy dose distributions by simulated annealing. , 1989, Physics in medicine and biology.

[14]  X Allen Li,et al.  Radiation dose-volume effects in the stomach and small bowel. , 2010, International journal of radiation oncology, biology, physics.

[15]  M. Kusunoki,et al.  The effectiveness of preoperative intraluminal brachytherapy in preventing wall penetration and nodal involvement of rectal carcinomas , 2000, Surgery Today.

[16]  H. Wong,et al.  High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[17]  Paul H. Calamai,et al.  Projected gradient methods for linearly constrained problems , 1987, Math. Program..

[18]  E Pantelis,et al.  Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part II: Monte Carlo and experimental verification of a multiple source dwell position plan employing a shielded applicator. , 2011, Medical physics.

[19]  Kari Tanderup,et al.  Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al(2)O(3):C dosimetry and a novel statistical error decision criterion. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  Frank Verhaegen,et al.  Image-guided high dose rate endorectal brachytherapy. , 2007, Medical physics.

[21]  M A Ebert,et al.  Possibilities for intensity-modulated brachytherapy: technical limitations on the use of non-isotropic sources. , 2002, Physics in medicine and biology.

[22]  Cornelis Verhoef,et al.  Management of locally advanced primary and recurrent rectal cancer. , 2007, Clinics in colon and rectal surgery.

[23]  Slobodan Devic,et al.  Advantages of inflatable multichannel endorectal applicator in the neo‐adjuvant treatment of patients with locally advanced rectal cancer with HDR brachytherapy , 2005, Journal of applied clinical medical physics.

[24]  Frank Verhaegen,et al.  Dosimetric characterization of a novel intracavitary mold applicator for Ir192 high dose rate endorectal brachytherapy treatment. , 2006, Medical physics.

[25]  Mokhtar S. Bazaraa,et al.  Nonlinear Programming: Theory and Algorithms , 1993 .

[26]  E Podgorsak,et al.  High dose rate endorectal brachytherapy as a neoadjuvant treatment for patients with resectable rectal cancer. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[27]  Christine Haie-Meder,et al.  36 The heterogeneity index (HI): A new parameter to evaluate tumor local control and late morbidity in interstitial brachytherapy , 1996 .

[28]  M. A. Ebert,et al.  Potential dose-conformity advantages with multi-source intensity-modulated brachytherapy (IMBT) , 2006, Australasian Physics & Engineering Sciences in Medicine.

[29]  Tamim Niazi,et al.  High Dose Rate Endorectal Brachytherapy for Patients With Curable Rectal Cancer , 2010 .

[30]  Niko Papanikolaou,et al.  Three dimensional intensity modulated brachytherapy (IMBT): dosimetry algorithm and inverse treatment planning. , 2010, Medical physics.

[31]  Steve B. Jiang,et al.  Ultrafast treatment plan optimization for volumetric modulated arc therapy (VMAT) , 2010, 1005.4396.

[32]  L. Anderson,et al.  Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .

[33]  J. Williamson,et al.  Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. , 2004 .

[34]  P. Hoskin,et al.  High-dose-rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma. , 2010, Brachytherapy.

[35]  J. Borrás,et al.  Evidence and research in rectal cancer. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  Frank Verhaegen,et al.  Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator. , 2008, International journal of radiation oncology, biology, physics.

[37]  B R Thomadsen,et al.  Development of an adjoint sensitivity field-based treatment-planning technique for the use of newly designed directional LDR sources in brachytherapy. , 2012, Physics in medicine and biology.